Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Open-Label Randomized Controlled Study of Ciprofloxacin vs Rifaximin as Neutropenia Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation.
Gavriilaki E, Mallouri D, Laspa E, Papakonstantinou A, Lazaridou A, Varelas C, Baldoumi E, Giannakopoulou A, Demosthenous C, Vardi A, Bousiou Z, Batsis I, Gkioula G, Anagnostopoulos A, Sakellari I. Gavriilaki E, et al. Among authors: batsis i. Transplant Proc. 2024 Mar;56(2):380-385. doi: 10.1016/j.transproceed.2023.12.010. Epub 2024 Feb 16. Transplant Proc. 2024. PMID: 38368126 Free article. Clinical Trial.
Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E, Sakellari I, Batsis I, Mallouri D, Bousiou Z, Vardi A, Yannaki E, Constantinou V, Tsompanakou A, Vadikoliou C, Kaloyannidis P, Bamihas G, Anagnostopoulos A. Gavriilaki E, et al. Among authors: batsis i. Clin Transplant. 2018 Sep;32(9):e13371. doi: 10.1111/ctr.13371. Epub 2018 Aug 20. Clin Transplant. 2018. PMID: 30080283
Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid Malignancies.
Sakellari I, Gavriilaki E, Mallouri D, Batsis I, Varelas C, Tagara S, Bousiou Z, Papathanasiou M, Vardi A, Papalexandri A, Vadikoliou C, Athanasiadou A, Lalayanni C, Fylaktou A, Antoniadis K, Anagnostopoulos A. Sakellari I, et al. Among authors: batsis i. Transplant Cell Ther. 2021 Nov;27(11):916.e1-916.e6. doi: 10.1016/j.jtct.2021.07.020. Epub 2021 Jul 25. Transplant Cell Ther. 2021. PMID: 34320443 Free article.
Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-Disease.
Gavriilaki E, Sakellari I, Chatzikonstantinou T, Bousiou Z, Mallouri D, Masmanidou M, Vardi A, Koravou EE, Kika F, Touloumenidou T, Papalexandri A, Yannaki E, Batsis I, Anagnostopoulos A. Gavriilaki E, et al. Among authors: batsis i. Transplant Proc. 2021 Sep;53(7):2261-2266. doi: 10.1016/j.transproceed.2021.07.043. Epub 2021 Aug 18. Transplant Proc. 2021. PMID: 34417030
A non-interventional study of microcirculation dynamics in allogeneic hematopoietic cell transplantation survivors compared to controls: evidence of impaired microvascular response regardless of conventional cardiovascular risk factors.
Gavriilaki E, Anyfanti P, Sakellari I, Batsis I, Dolgyras P, Lazaridis A, Nikolaidou B, Koletsos N, Gavriilaki M, Zarifis I, Masmanidou M, Bousiou Z, Vardi A, Douma S, Anagnostopoulos A, Gkaliagkousi E. Gavriilaki E, et al. Among authors: batsis i. Bone Marrow Transplant. 2022 Jan;57(1):72-77. doi: 10.1038/s41409-021-01500-w. Epub 2021 Oct 13. Bone Marrow Transplant. 2022. PMID: 34645924
Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer.
Kaloyannidis P, Batsis I, Yannaki E, Adamidou D, Bartzoudis D, Papathanasiou M, Mallouri D, Sakellari I, Fassas A, Anagnostopoulos A. Kaloyannidis P, et al. Among authors: batsis i. Biol Blood Marrow Transplant. 2007 Sep;13(9):1049-56. doi: 10.1016/j.bbmt.2007.05.009. Epub 2007 Jul 16. Biol Blood Marrow Transplant. 2007. PMID: 17697967 Free article.
GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation.
Sakellari I, Barbouti A, Bamichas G, Mallouri D, Kaloyannidis P, Fragidis S, Batsis I, Apostolou C, Karpouza A, Yannaki E, Smias C, Sombolos K, Anagnostopoulos A. Sakellari I, et al. Among authors: batsis i. Bone Marrow Transplant. 2013 Oct;48(10):1329-34. doi: 10.1038/bmt.2013.55. Epub 2013 Apr 15. Bone Marrow Transplant. 2013. PMID: 23584436
Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation.
Sakellari I, Mallouri D, Gavriilaki E, Batsis I, Kaliou M, Constantinou V, Papalexandri A, Lalayanni C, Vadikolia C, Athanasiadou A, Yannaki E, Sotiropoulos D, Smias C, Anagnostopoulos A. Sakellari I, et al. Among authors: batsis i. Biol Blood Marrow Transplant. 2017 Mar;23(3):445-451. doi: 10.1016/j.bbmt.2016.11.023. Epub 2016 Nov 30. Biol Blood Marrow Transplant. 2017. PMID: 27914967 Free article.
The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies.
Sakellari I, Batsis I, Bousiou Z, Mallouri D, Constantinou V, Gavriilaki E, Smias C, Yannaki E, Kaloyannidis P, Papaioannou G, Stavroyianni N, Syrigou A, Sotiropoulos D, Fylaktou A, Tsompanakou A, Saloum R, Anagnostopoulos A. Sakellari I, et al. Among authors: batsis i. Clin Lymphoma Myeloma Leuk. 2017 Oct;17(10):658-666. doi: 10.1016/j.clml.2017.06.008. Epub 2017 Jun 29. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28716402
71 results